Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation

Autologous hematopoietic stem cell transplantation (AHSCT) is an increasingly used curative treatment for some solid tumors in children. Instead of allogeneic transplantation, the risk of developing graft-versus-host disease (GvHD) is much lower after AHSCT. Although the clinical findings of auto-GV...

Full description

Bibliographic Details

Published in:	Journal of Pediatric Research
Main Authors:	Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, Ahmet Koç
Format:	Article
Language:	English
Published:	Ege University, Faculty of Medicine, Department of Pediatrics and Ege Children Foundation 2022-06-01
Subjects:	autologous stem cell transplantation children graft versus host disease ruxolitinib steroid-resistant
Online Access:	http://jpedres.org/archives/archive-detail/article-preview/successful-treatment-of-refractory-graft-versus-ho/52013